AlloSource Receives Patent for ProChondrix Cartilage Repair Product

By Julie A. Vetalice

AlloSource was awarded U.S. Patent No. 9,186,253, Cartilage mosaic compositions and methods, for its ProChondrix® Cartilage Restoration Matrix allograft product.

As a cellular 3D fresh cartilage matrix format, ProChondrix provides live functional cells and biological components to support repair and regeneration of damaged cartilage tissues.

Source: AlloSource

The new patent follows three secured at the close of 2015 for AlloSource:

  • U.S. Patent No. 9,192,695, Allografts combined with tissue derived stem cells for bone healing, relating to AlloStem® Cellular Bone Allograft
  • U.S. Patent No. 9,168,140, Perforated osteochondral allograft compositions, addressing donated osteochondral tissue with a bone and cartilage layer perforated with small holes to allow for cellular migration and osteochondral repair
  • U.S. Patent No. 9,186,380, Minced cartilage systems and methods, covering donated cartilage tissue processed to include small particles of cartilage containing living chondrocytes

 

Product Labels: Orthobiologic Soft Tissue Repair

Tags: Patent